Sanofi ready to offer doses of Plaquenil, a promising antimalarial

0
109
Sanofi ready to offer doses of Plaquenil, a promising antimalarial


According to a study carried out on 24 patients, six days after starting Plaquenil, the virus had disappeared in three quarters of the people treated.



© afp.com/ERIC PIERMONT
Sanofi’s treatment has been described as


Towards treatment against the new coronavirus? The French laboratory Sanofi said it was ready to offer the French authorities millions of doses of the antimalarial Plaquenil, which could potentially treat 300,000 patients, after trials deemed “promising” in patients with Covid-19.

In view of a study with encouraging results conducted on this drug, “Sanofi is committed to making its treatment available to France and to offering several million doses that could treat 300,000 patients,” said on Tuesday spokesperson for the laboratory, while specifying that the group stood ready to work with French health authorities “to confirm these results”.

READ ALSO >> Why coronavirus seems more deadly in Italy than in China and France

Plaquenil, a hydroxychloroquine molecule, also used for decades in autoimmune diseases like lupus or rheumatoid arthritis, could indeed have an effect on the disappearance of the virus, said Monday Professor Didier Raoult, director of the ‘University Hospital Institute of Marseille.

According to this study conducted by Professor Raoult on 24 patients with coronavirus, six days after the start of taking Plaquenil, the virus had disappeared in three quarters of those treated.

Calls for caution

Earlier today, French government spokeswoman Sibeth Ndiaye said that clinical trials were “promising” and would be spread over a larger number of patients. These new clinical trials “will be carried out with a team independent of the professor [Didier] Raoult “, said Sibeth Ndiaye after a Council of Ministers, stressing that at this stage” we have no scientific proof “that this treatment works.

Several experts indeed call for caution in the absence of further studies and because of the undesirable effects which can be serious, in particular in the event of overdose.

READ ALSO >> Coronavirus: scientists who whisper in the President’s ear

“I have taken note of the results and have given the authorization so that a larger trial by other teams can be initiated as soon as possible on a larger number of patients,” said his side. during a telephone press conference the Minister of Health Olivier Veran.

The latter expressed the hope that these new tests would “consolidate the interesting results” obtained by Professor Raoult. But “it is absolutely fundamental to base any decision of public health policy on validated scientific data, and the validation processes, one cannot negotiate with”, he underlined about these tests.

Business initiatives are multiplying facing the pandemic. Last Friday, Sanofi, which works on a vaccine against the new coronavirus, had already announced the creation of a seed fund to support the research effort of the teams of the Assistance Publique Hôpitaux de Paris (AP-HP) in their fight against the coronavirus.

Sunday, the luxury group LVMH also said to act by announcing that its perfume branch was going to manufacture hydroalcoholic gels made available free of charge to French health authorities.

LEAVE A REPLY

Please enter your comment!
Please enter your name here